Chargement en cours...
S32. EFFICACY AND SAFETY OF PALIPERIDONE PALMITATE ONCE-MONTHLY IN PATIENTS WITH SCHIZOPHRENIA WITH LOW, MODERATE, AND HIGH RECENT DISEASE ACTIVITY AT BASELINE
BACKGROUND: Paliperidone palmitate once-monthly (PP1M) is a long-acting injectable formulation that eliminates the need for daily dosing, ensures sustained plasma levels for several weeks, and helps clinicians reliably monitor adherence. We examined the efficacy and safety of PP1M in patients with s...
Enregistré dans:
| Publié dans: | Schizophr Bull |
|---|---|
| Auteurs principaux: | , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Oxford University Press
2019
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6455751/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/schbul/sbz020.577 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|